Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients

Cited by papers we hold 4

• Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines? · 2019
  No notice
• Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events · 2019
  No notice
• NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy · 2018
  No notice
• Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.